Home > What we do > Medicine & Healthcare > hMedicine > hMedicine Story

Hadassah’s Prof. Eitan Kerem Receives European Cystic Fibrosis Society 2014 Prize

Prof. Kerem (left) receiving prize from ECFS President Stuart Elborn

Prof. Eitan Kerem, world-renowned cystic fibrosis specialist and head of the Hadassah Medical Organization’s Division of Pediatrics, has been awarded the European Cystic Fibrosis Society (ECFS)’s 2014 prize for his outstanding work in CF.

Prof. Kerem is the principal investigator of many national and international multi-center clinical trials and author of over 170 papers in the field of pulmonology. His research spans such topics as the association between phenotype and genotype, prediction of disease severity and mortality, molecular mechanisms that affect variability in disease, and development of new mutation-specific pharmacological therapies to correct the basic defects in CF. Prof. Kerem was also instrumental in formulating the guidelines that paved the road toward the standardization of CF care in Europe and other parts of the world.

At the same time, Prof. Kerem has been a leader in promoting the rights of children with chronic diseases and advocating for proper care of these children. He has also been at the forefront of building bridges to peace through medicine, sharing his expertise with Palestinian colleagues and promoting professional exchanges between Palestinians and Israelis.

Prof. Kerem has served as Chairman of the Medical Advisory Board of Israel’s CF Foundation and on the board of the ECFS, as well as president of the International Congress on Pediatric Pulmonology.

Date: 6/19/2014

Hadassah Stem Cell Expert Speaks at TEDx Conference in Jaffa

FDA Grants Approval for US Clinical Trials of Hadassah-Developed Technology to Treat Fatty Liver Disease

Hadassah Physicians Receive Prestigious Grants and Awards

New Research at Hadassah: Computational Tools Unravel the Mystery of Transient Amnesia

From Life-Threatening Brain Bleed to Birth of a Daughter

Cookbook Author, Rabbi Marks, Spends Last Days at Hadassah's Hospice

Hadassah’s Revolutionary Tipat Halav Clinics of 1920s Featured in Jerusalem Old City Museum

Victims of Terror Share Their Stories of Anguish and Appreciation with Hadassah President

Hadassah’s Advanced Gene Sequencing Changes the Life of a Family from Uzbekistan

IDF Medic Heroically Battles Terrorist, Both Treated at Hadassah

Orthopedic Trauma Turns Tragedy into Innovation at Hadassah

On the Cutting-Edge of Melanoma Treatment: Hadassah’s Protocols and Research

Saving a Newborn from a Life Without Sight

Terrorist and Victim Sent to Hadassah's Hospitals After Third Attack in Two Weeks

Three Sent to Hadassah After Second Jerusalem Terror Attack of the Week

Clinical Trial of Hadassah-Developed Stem Cell Treatment for Macular Degeneration Gets Go-Ahead from FDA

“We Don’t Say ‘No’,” Hadassah Neurosurgeon Explains in Operating on 82-Year-Old Patient

Cutting-Edge Medicine and Research; a Role Model for Peace: A Briefing from the Hospital's Director General

4 Ways Hadassah Hospital is Preparing for Ebola—Just in Case

Hailing from 17 Countries: the 39th Graduation Class of Hadassah’s International Master of Public Health Program



More hMedicine Stories




Hadasit, Hadassah’s Technology Transfer Arm, Reviews 2012’s Accomplishments

When the Hadassah University Medical Center’s physicians suggest a solution to a medical problem which can lead to the development of a new medicine or product, Hadasit, Hadassah’s technology transfer arm, explores its feasibility and supports the promotion of those viable ideas with innovation potential. Although 2012 has been “a year full of challenges for the life science industry,” says Einat Zisman, Hadasit’s Chief Executive Officer, Hadasit still signed 125 agreements for clinical trials, all to be done at Hadassah. In addition, Hadasit signed 15 agreements for cooperation and commercialization of technologies that were developed at Hadassah. Click here to read the latest Newsletter from Hadasit >>

   |  Who We Are  |  What We Do  |  Where We Do It  |  Read About It  |  Join Now  |  Donate  |
  |  Login  |  Contact Us  |  Careers  |  Terms & Conditions  |  
Copyright ©2014 Hadassah is a registered trademark of Hadassah, the Women's Zionist Organization of America